ATE226451T1 - Verfahren zum lösen von pharmazeutischen wirkstoffen in wasser und in wässrige träger - Google Patents
Verfahren zum lösen von pharmazeutischen wirkstoffen in wasser und in wässrige trägerInfo
- Publication number
- ATE226451T1 ATE226451T1 AT98937757T AT98937757T ATE226451T1 AT E226451 T1 ATE226451 T1 AT E226451T1 AT 98937757 T AT98937757 T AT 98937757T AT 98937757 T AT98937757 T AT 98937757T AT E226451 T1 ATE226451 T1 AT E226451T1
- Authority
- AT
- Austria
- Prior art keywords
- water
- complex
- pharmaceutically active
- active ingredients
- pharmaceutical active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000456A IT1294205B1 (it) | 1997-07-23 | 1997-07-23 | Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive |
PCT/IT1998/000206 WO1999004823A1 (en) | 1997-07-23 | 1998-07-22 | Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE226451T1 true ATE226451T1 (de) | 2002-11-15 |
Family
ID=11405192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98937757T ATE226451T1 (de) | 1997-07-23 | 1998-07-22 | Verfahren zum lösen von pharmazeutischen wirkstoffen in wasser und in wässrige träger |
Country Status (11)
Country | Link |
---|---|
US (1) | US6346273B1 (de) |
EP (1) | EP0994727B1 (de) |
JP (1) | JP2001510810A (de) |
AT (1) | ATE226451T1 (de) |
AU (1) | AU8645098A (de) |
DE (1) | DE69808911T2 (de) |
EA (1) | EA002326B1 (de) |
ES (1) | ES2186197T3 (de) |
IT (1) | IT1294205B1 (de) |
PT (1) | PT994727E (de) |
WO (1) | WO1999004823A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19845305A1 (de) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen |
WO2002028363A1 (en) * | 2000-10-05 | 2002-04-11 | Unimed Pharma Spol S.R.O. | Eye instillation with decongestant effect |
US6866396B2 (en) * | 2002-10-09 | 2005-03-15 | Jji Lighting Group, Inc. | Illuminating device with rotatably adjustable support |
US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
WO2005046575A2 (en) * | 2003-07-29 | 2005-05-26 | Signature R & D Holdings, Lcc | Amino acid prodrugs |
US6960300B2 (en) * | 2003-09-08 | 2005-11-01 | Sami Labs Limited | Process for preparing water soluble diterpenes and their applications |
WO2005105040A2 (en) * | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
CA2571554A1 (en) * | 2004-06-28 | 2006-01-19 | Alza Corporation | A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
US20100239629A1 (en) * | 2006-07-31 | 2010-09-23 | Isp Investments Inc. | Delivery system for delivering bioactive materials |
US20100260691A1 (en) * | 2006-07-31 | 2010-10-14 | Narayanan Kolazi S | Aqueous compositions containing a hydrophobic material |
WO2008035109A1 (en) | 2006-09-22 | 2008-03-27 | Cipla Limited | Rifaximin |
US8747871B2 (en) * | 2006-09-28 | 2014-06-10 | Isp Investments Inc. | Synergistic matrix composite for making stable microemulsions of active ingredients |
US9717584B2 (en) * | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
JP5756020B2 (ja) * | 2008-12-10 | 2015-07-29 | シプラ・リミテッド | リファキシミン複合体 |
RU2523562C1 (ru) * | 2013-05-23 | 2014-07-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) | Способ получения таблеток рутина |
US9814560B2 (en) | 2013-12-05 | 2017-11-14 | W. L. Gore & Associates, Inc. | Tapered implantable device and methods for making such devices |
CN110946684B (zh) | 2015-06-05 | 2022-06-03 | W.L.戈尔及同仁股份有限公司 | 带有渐缩部的低渗血量可植入假体 |
WO2017103840A1 (en) * | 2015-12-16 | 2017-06-22 | MOHAMED ABDULLA ANZAR, Cheppattu | A water soluble 10% w/w forskolin composition and a method of synthesizing the same |
RS61915B1 (sr) * | 2017-01-09 | 2021-06-30 | Scipharm S A R L | Novi postupak za pripremu forskolina rastvorljivog u vodi |
JP6506787B2 (ja) | 2017-03-06 | 2019-04-24 | ストローブ株式会社 | 成膜方法 |
JP2023511432A (ja) | 2020-01-23 | 2023-03-17 | サイファーム ソシエテ ア レスポンサビリテ リミテ | 7-デアセチル-フォルスコリンとpvpの複合体 |
KR20220149987A (ko) * | 2021-05-03 | 2022-11-10 | 연세대학교 산학협력단 | 안구건조증 또는 안구건조증 연관 안과 질환의 예방, 개선 또는 치료용 조성물 |
WO2023027670A2 (en) * | 2021-08-23 | 2023-03-02 | Tum Ekip Ilac Anonim Sirketi | Lyophilized levosimendan compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
US4900775A (en) | 1988-02-29 | 1990-02-13 | Gaf Chemicals Corporation | Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
AU5036590A (en) | 1989-02-24 | 1990-09-26 | Gaf Chemicals Corporation | Solubilization of indomethacin and piroxicam by a quaternized polymer |
IL89530A0 (en) | 1989-03-08 | 1989-09-10 | Jeffrey J Feigenbaum | Compositions containing forskolin |
US5141961A (en) * | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
BR9507768A (pt) * | 1994-05-27 | 1997-09-02 | Farmarc Nederland Bv | Composição farmacêutica |
KR100966245B1 (ko) * | 1997-03-12 | 2010-06-28 | 아보트 러보러터리즈 | 사이클로스포린 투여용 친수성 2원 시스템 |
-
1997
- 1997-07-23 IT IT97RM000456A patent/IT1294205B1/it active IP Right Grant
-
1998
- 1998-07-22 DE DE69808911T patent/DE69808911T2/de not_active Expired - Fee Related
- 1998-07-22 ES ES98937757T patent/ES2186197T3/es not_active Expired - Lifetime
- 1998-07-22 PT PT98937757T patent/PT994727E/pt unknown
- 1998-07-22 EP EP98937757A patent/EP0994727B1/de not_active Expired - Lifetime
- 1998-07-22 US US09/463,331 patent/US6346273B1/en not_active Expired - Fee Related
- 1998-07-22 AU AU86450/98A patent/AU8645098A/en not_active Abandoned
- 1998-07-22 JP JP2000503874A patent/JP2001510810A/ja active Pending
- 1998-07-22 EA EA200000154A patent/EA002326B1/ru not_active IP Right Cessation
- 1998-07-22 WO PCT/IT1998/000206 patent/WO1999004823A1/en active IP Right Grant
- 1998-07-22 AT AT98937757T patent/ATE226451T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ITRM970456A1 (it) | 1999-01-23 |
AU8645098A (en) | 1999-02-16 |
DE69808911T2 (de) | 2003-06-12 |
WO1999004823A1 (en) | 1999-02-04 |
ITRM970456A0 (de) | 1997-07-23 |
PT994727E (pt) | 2003-03-31 |
EA002326B1 (ru) | 2002-04-25 |
ES2186197T3 (es) | 2003-05-01 |
IT1294205B1 (it) | 1999-03-24 |
EA200000154A1 (ru) | 2000-10-30 |
US6346273B1 (en) | 2002-02-12 |
EP0994727A1 (de) | 2000-04-26 |
EP0994727B1 (de) | 2002-10-23 |
JP2001510810A (ja) | 2001-08-07 |
DE69808911D1 (de) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE226451T1 (de) | Verfahren zum lösen von pharmazeutischen wirkstoffen in wasser und in wässrige träger | |
NO971898D0 (no) | Farmasöytiske preparater | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
FR2635265B1 (fr) | Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation | |
NL930038I2 (nl) | Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten. | |
DK0580817T3 (da) | Farmaceutisk præparat og fremgangsmåde til fremstilling deraf | |
ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
NO20005431D0 (no) | Gelérbare farmasøytiske preparater | |
HUP0200114A2 (hu) | Bioaktív komplexek kapszulázása liposzómákba | |
KR970061270A (ko) | 히토성장호르몬을 함유하는 의약제제 | |
IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
ATE289801T1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
ATE136783T1 (de) | Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n- methylpiperidino)-ethyl>-phosphat und verfahren zu dessen herstellung | |
ATE106883T1 (de) | Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten. | |
DE59711745D1 (de) | Schaumförmige Zubereitungen mit einem Gehalt an grenzflächenaktiven Substanzen und Elektrolyten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0994727 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |